Detalhe da pesquisa
1.
Immunogenicity of a Live-Attenuated Dengue Vaccine Using a Heterologous Prime-Boost Strategy in a Phase 1 Randomized Clinical Trial.
J Infect Dis
; 223(10): 1707-1716, 2021 05 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-32966573
2.
A Phase 1, Open-Label Assessment of a Dengue Virus-1 Live Virus Human Challenge Strain.
J Infect Dis
; 223(2): 258-267, 2021 02 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32572470
3.
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials.
Lancet
; 391(10120): 563-571, 2018 02 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-29217375
4.
All-natural chitosan-based polyimine vitrimer with multiple advantages: A novel strategy to solve nondegradable plastic waste pollution.
J Hazard Mater
; 465: 133030, 2024 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-38006859
5.
Safety and immunogenicity of a purified inactivated Zika virus vaccine candidate in adults primed with a Japanese encephalitis virus or yellow fever virus vaccine in the USA: a phase 1, randomised, double-blind, placebo-controlled clinical trial.
Lancet Infect Dis
; 23(10): 1175-1185, 2023 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-37390836
6.
Thermo-processable chitosan-based plastic substitute with self-adaptiveness and closed-loop recyclability.
Carbohydr Polym
; 291: 119479, 2022 Sep 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35698320
7.
Characterization of B-cell and T-cell responses to a tetravalent dengue purified inactivated vaccine in healthy adults.
NPJ Vaccines
; 7(1): 132, 2022 Oct 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-36316335
8.
Safety and immunogenicity of a plant-derived recombinant protective antigen (rPA)-based vaccine against Bacillus anthracis: A Phase 1 dose-escalation study in healthy adults.
Vaccine
; 40(12): 1864-1871, 2022 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35153091
9.
Pre-existing Immunity to Japanese Encephalitis Virus Alters CD4 T Cell Responses to Zika Virus Inactivated Vaccine.
Front Immunol
; 12: 640190, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-33717194
10.
Cell-Mediated Immunity Generated in Response to a Purified Inactivated Vaccine for Dengue Virus Type 1.
mSphere
; 5(1)2020 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31969476
11.
Safety and Immunogenicity of Different Formulations of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico: Final Results after 3 Years of Follow-Up from a Randomized, Placebo-Controlled Phase I Study.
Am J Trop Med Hyg
; 102(5): 951-954, 2020 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32124728
12.
Safety and Immunogenicity of an AS03B-Adjuvanted Inactivated Tetravalent Dengue Virus Vaccine Administered on Varying Schedules to Healthy U.S. Adults: A Phase 1/2 Randomized Study.
Am J Trop Med Hyg
; 103(1): 132-141, 2020 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-32342848
13.
Phase I Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults from Puerto Rico.
Am J Trop Med Hyg
; 98(5): 1435-1443, 2018 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29512481
14.
Phase 1 Randomized Study of a Tetravalent Dengue Purified Inactivated Vaccine in Healthy Adults in the United States.
Am J Trop Med Hyg
; 96(6): 1325-1337, 2017 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-28719287
15.
Safety and Immunogenicity of a Dengue Virus Serotype-1 Purified-Inactivated Vaccine: Results of a Phase 1 Clinical Trial.
Am J Trop Med Hyg
; 93(3): 454-460, 2015 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-26149862
16.
Electrochemical behavior of dye-linked L-proline dehydrogenase on glassy carbon electrodes modified by multi-walled carbon nanotubes.
Beilstein J Nanotechnol
; 1: 135-41, 2010.
Artigo
em Inglês
| MEDLINE | ID: mdl-21977403
17.
Rocky Mountain spotted fever.
Dis Mon
; 58(6): 361-9, 2012 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-22608123
18.
Respiratory tract infections in athletes.
Dis Mon
; 56(7): 407-13, 2010 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-20621214